Clinical Trial Update: Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fluoride varnish with CPP-ACP for reducing oral and salivary symptoms in chemotherapy patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucositis
• Xerostomia

Drugs mentioned

• CPP-ACP (Casein phosphopeptide-amorphous calcium phosphate) (Casein phosphopeptide-amorphous calcium phosphate)
• Fluoride Varnish (sodium fluoride varnish)

Snippet

Sponsor: Azad University of Medical Sciences | Conditions: Mucositis, Dry Mouth | Phase 2 | Status: COMPLETED